MRNA Financials
Moderna Inc - Financial statements & key metrics
Stock Price
$136.60
Market Cap
$24.52B
P/E Ratio
-18.8
EPS
$-9.43
Income Statement Highlights
Most Recent Quarter: FY
Revenue
$1.94B
Gross Profit
$1.08B
Operating Income
$-3.07B
Net Income
$-2.82B
EPS (Diluted)
$-7.26
Balance Sheet Highlights
Total Assets
$12.34B
Total Liabilities
$3.69B
Shareholders Equity
$8.65B
Cash & Equivalents
$2.60B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-1.87B
CapEx
$192.00M
Free Cash Flow
$-1.68B
Profitability Metrics
Gross Margin
55.3%
Operating Margin
-25.6%
Net Margin
-139.6%
ROE
-29.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MRNA revenue?
MRNA's most recent quarterly revenue was $1.94B. Annual revenue can be calculated by summing the four most recent quarters.
Is MRNA profitable?
MRNA reported a loss of $2.82B in the most recent quarter. The net profit margin is -139.6%.
What is MRNA market cap?
MRNA has a market capitalization of $24.52B, making it a large-cap stock.
Does MRNA have debt?
View MRNA's balance sheet for debt information.
What is MRNA cash flow?
MRNA's most recent quarterly free cash flow was $-1.68B.